Jonathan C. Javitt, M.D., M.P.H. Email and Phone Number
Jonathan C. Javitt, M.D., M.P.H. work email
- Valid
- Valid
- Valid
- Valid
- Valid
Jonathan C. Javitt, M.D., M.P.H. personal email
- Valid
Jonathan C. Javitt, M.D., M.P.H. phone numbers
A physician with a background in ophthalmology, drug development, information technology, health economics, outcomes research, and public health. Dr. Javitt is currently Founder, Chairman, and CEO of NRx Pharmaceuticals, Inc. Previously co-founder of health information technology companies that have merged with Siemens, Inc., United Health Group, Inc., 3M, Philips, and Aetna, Inc. Appointed roles as a Special Government Employee in the Reagan, Bush '41, Clinton, and Bush '43 administrations related to health care and national security. Appointed by President Bush to Chair Health Committee of President's Information Technology Advisory Committee (PITAC). Their report, Revolutionizing Health Care through Information Technology created the Office of the National Coordinator for Health IT. Served as Special Employee of Undersecretary of Defense and continues to serve as a senior fellow in National Security Health Policy Center of the Potomac Institute.Previous expert consultant to the World Bank, the National Institutes of Health, the Health Care Financing Administration, Department of Veterans Affairs, and the ministries of health of United Kingdom, Sweden, Australia, Japan, and the Netherlands.Adjunct Professor, Wilmer Eye Institute, Johns Hopkins School of Medicine. Authored the first book on computers in medicine and has published more than 200 scientific works in peer-reviewed journals. His first novel, Capitol Reflections, was published by Sterling and Ross, to critical acclaim.Specialties: Health Policy, Pharmacoeconomics, Pharmaceutical regulatory and reimbursement policy, Ophthalmology (glaucoma), Epidemiology, Technology assessment, Care policy, Health Services Research, cost-effectiveness, Payer policy, Software design and development.
-
Founder, Chairman, And CeoNrx Pharmaceuticals, Inc. Dec 2023 - PresentWilmington, Delaware, Us -
Chief Scientist, Director, And FounderNrx Pharmaceuticals, Inc. Mar 2022 - Dec 2023Wilmington, Delaware, UsNRx boldly addresses the life-threatening diseases facing the world today that often go untreated – by researching, developing, and scaling solutions to help people who most desperately need them.We leverage proven science and clinical expertise to identify and apply medical solutions as immediately as possible, while simultaneously focusing on expanding the therapeutic potential for the future. -
Senior FellowPotomac Institute For Policy Studies Nov 2001 - PresentArlington, Virginia , UsI joined the faculty of the Potomac Institute on the afternoon of September 11, 2001 based on a suddenly-inspired commitment to assist the United States in facing the challenges of the 21st century. The Potomac Institute for Policy Studies is an independent, 501(c)(3), not-for-profit public policy research institute. The Institute identifies and aggressively shepherds discussion on key science, technology, and national security issues facing our society, providing in particular, an academic forum for the study of related policy issues. From these discussions and forums, we develop meaningful policy options and ensure their implementation at the intersection of business and government. The Institute’s current endeavors have required the formation of special efforts in: Terrorism and asymmetry; Emerging threats and opportunities; National health policies; Science and technology forecasting; and National security. -
Professor Of Ophthalmology (Adj)Johns Hopkins Medicine Jul 1988 - PresentBaltimore, Md, UsAlthough my career has offered me many opportunities that go beyond the bounds of traditional Ophthalmology, I continue to serve proudly on the faculty of what many view as the leading ophthalmologic institute in the US. My ongoing involvements include resident and medical student teaching and collaborative research projects focused on detection and prevention of blinding eye disease. -
Founder And CeoNeurorx, Inc. Jun 2015 - May 2021NeuroRx, Inc., is a clinical stage pharmaceutical company that is developing Cyclurad™, a proprietary formulation of D-cycloserine and Lurasidone, intended for the treatment of bipolar depression and suicidality. The Company is conducting R&D activities in Israel and the United States.
-
Founder, Vice ChairmanTelcare, Inc. Jan 2009 - Sep 2015Malvern, Pennsylvania, UsTelcare connects the last mile between patient and caregiver using wireless M2M technology. The company’s first product, cleared by FDA in Q3 2011 is the world’s first cellular glucose meter, providing instant transmission of glucose testing results to a care management server and instant feedback and coaching to the patient. The global market for glucose meters and strips is in excess of $12 billion and includes the 28 million Americans who have diabetes.By relaying glucose testing data to caregivers and involved family members, Telcare's solution creates an ecosystem of care that empowers people with diabetes to better manage their condition every day. Telcare's product has recently been recognized with two First Place E-Tech awards by the CTIA (best Mobile Health Soluiton and best Enterprise Health Solution), a First Prize for Best Patient Monitoring Solution by Frost and Sullivan, and recognition as a Finalist for the Triple Tree iAward. -
Venture PartnerPontifax, Lp 2000 - 2015
-
Venture PartnerPontifax, Lp 2000 - 2015
-
Venture PartnerPontifax, Lp 2000 - 2015
-
FounderCoderyte Jan 1999 - Dec 2005UsCompany founder, inventor, investor, board memberCoderyte was the first company to use Natural Language Processing technology for the interpretation of medical record data. At the time of Coderyte's sale to 3M corporation, its technology was being used to assign accurate diagnosis and procedure codes to more than 1 million medical records per month with an accuracy that far surpassed trained human coders. -
Member, Office Of The CeoFirst Consulting Group Apr 2004 - Apr 2005UsI joined the company for a year in order to help develop the First Gateways product that is rapidly becoming the leading RHIO (Regional Health Information Organization) solution in the US and Canada. First Gateways enables the transport of vital health information for the benefit of patients and their caregivers across otherwise unrelated sites of care including hospitals, physicians offices, medical laboratories, and others. -
Committee Chair, President'S Information Technology Advisory CommitteeThe White House, Executive Office Of The President Apr 2002 - Apr 2004Commissioned by President George W. Bush to lead the Health Committee of the President's Information Technology Advisory Committee. Led the initiative which produced PITAC's Report to the President: Revolutionizing Healthcare through Information Technology. This report and the surrounding body of work resulted in Executive Order 33335, establishing the Office of the National Coordinator for Health Information Technology. As President Bush said in his 2002 State of the Union Address, "electronic medical records save lives and save money."
-
Executive Vp And Chief Scientific OfficerActive Health Management 1999 - 2004Active Health Management was acquired by Aetna, Inc., in 2004 and remains a wholly-owned subsidiary. Active Health pioneered the use of health information technology to identify common medical errors and deviations from best medical practices in the care of Americans with major illnesses. We developed the Care Engine, a proprietary product that assembles a virtual medical record from the insurance claims and online laboratory data of an individual and uses that information to alert the patient's own caregivers to life-threatening and also less acute opportunities to improve care. In a prospective trial of 40,000 people, we proved that this approach substantially reduced acute hospital admission and potentially saved significant health-related cost as well.
-
Senior Vp And National Medical DirectorIngenix, Inc Jun 1996 - Jun 1997UsI was invited by United Health Care to serve as the founding National Medical Director and Senior Vice President of a newly formed division, Ingenix (now Optum Insight). This division, built around the work of Certitude and several other acquisitions continues to be a leading organization in harnessing the power of medical information to promote better decision making and prioritization within our health care system. -
Professor Of Ophthalmology And Public Policy/ Director Glaucoma ServiceGeorgetown University Medical Center Jan 1990 - Dec 1996Washington, Dc, UsDirector, Worthen Center for Eye Care ResearchDirector, Glaucoma ServiceSenior Faculty, Graduate program on Health PolicyCo-PI National Study on Breast Cancer Outcomes -
Founder And ChairmanCertitude, Inc 1994 - 1996I founded Certitude, Inc., based on a combination of my background as a health services researcher and my experiences on the White House Health Reform Task Force of 1994. The objective of Certitude was to harness the information available within administrative data, including insurance claims and similar information sources, in order to improve decisionmaking in the allocation of health care resources. The promise of Certitude's value proposition is demonstrated by the acquisition of Certitude by United Health Care, Inc. (NYSE:UNH) 18 months after its founding.
-
Resident SurgeonWills Eye Hospital Jul 1984 - Jun 1987Philadelphia, Pennsylvania, Us -
Kellogg Foundation Fellow In Health Policy And ManagementHarvard T.H. Chan School Of Public Health Sep 1983 - Jun 1984Boston, Massachusetts, Us -
Resident In MedicineLenox Hill Hospital Jul 1982 - Jun 1983New York, Ny, Us
Jonathan C. Javitt, M.D., M.P.H. Skills
Jonathan C. Javitt, M.D., M.P.H. Education Details
-
The Johns Hopkins UniversityFellowship In Ophthalmology -
Jefferson HealthWills Eye Hospital -
Harvard T.H. Chan School Of Public HealthHealth Policy And Management -
Cornell UniversityMedicine -
Princeton UniversityBiochemistry -
Mamaroneck High SchoolNew York State Regents Scholar
Frequently Asked Questions about Jonathan C. Javitt, M.D., M.P.H.
What company does Jonathan C. Javitt, M.D., M.P.H. work for?
Jonathan C. Javitt, M.D., M.P.H. works for Nrx Pharmaceuticals, Inc.
What is Jonathan C. Javitt, M.D., M.P.H.'s role at the current company?
Jonathan C. Javitt, M.D., M.P.H.'s current role is Founder, Chairman, and CEO, NRx Pharmaceuticals, Inc (Nasdaq:NRXP).
What is Jonathan C. Javitt, M.D., M.P.H.'s email address?
Jonathan C. Javitt, M.D., M.P.H.'s email address is in****@****inc.com
What is Jonathan C. Javitt, M.D., M.P.H.'s direct phone number?
Jonathan C. Javitt, M.D., M.P.H.'s direct phone number is +124039*****
What schools did Jonathan C. Javitt, M.D., M.P.H. attend?
Jonathan C. Javitt, M.D., M.P.H. attended The Johns Hopkins University, Jefferson Health, Harvard T.h. Chan School Of Public Health, Cornell University, Princeton University, Mamaroneck High School.
What are some of Jonathan C. Javitt, M.D., M.P.H.'s interests?
Jonathan C. Javitt, M.D., M.P.H. has interest in Skiing, Investing, Clay Shooting, Thriller Writing, Sailing, Health.
What skills is Jonathan C. Javitt, M.D., M.P.H. known for?
Jonathan C. Javitt, M.D., M.P.H. has skills like Healthcare, Public Health, Healthcare Information Technology, Health Policy, Strategy, Biotechnology, Entrepreneurship, Healthcare Management, Medical Devices, Epidemiology, Policy, Clinical Research.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial